| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.25 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.04 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-05 |